DIA Annual Canadian Meeting

Transformation with Collaboration

戻る Agenda

Session 5: Track C: Regulatory Considerations for Small- and Medium-Sized Enterprises

Session Chair(s)

Loretta Del Bosco

Director, Regulatory Affairs Quality Assurance Operations

AbbVie Corporation, Canada

The regulatory landscape in Canada is transforming rapidly. This session will allow for a better understanding of the challenges and opportunities faced by small- and medium-sized enterprises as they navigate the present and most importantly, the future in Canada. Whether you are from a large global or a small/medium-sized company, this session will provide transferable insights.

Learning Objective : At the conclusion of this session, participants should be able to:
Identify the regulatory process challenges of small/medium-sized companies
Describe how the regulatory revisions currently underway will affect small/medium-sized companies
Explain how small/medium-sized companies find opportunities to thrive in a regulated environment

Speaker(s)

Global R&D at Small Companies - Impact and Benefits of Harmonized Guidelines

Yatika Kohli, PhD, MBA

NoNO Inc, Canada

Chief Regulatory and Strategy Officer

Changes in the Regulatory Environment: Four Pillars of Impact for Small- and Medium-Sized Enterprises

Tammy Mitchell-Moore

Eisai Limited, Canada

Associate Director, Regulatory Affairs

Case Study: Practical Approach for a Small Company as a Product Goes Through the Health Canada Process

Joe O’neill

Accelera Pharma Canada, Canada

CEO